SEOUL, South Korea — DNA Link, Inc. and Amplicon Express announced that they established an agreement today for a strategic partnership for the delivery of the best quality genomics solutions. This strategic partnership will further strengthen the cooperative relationship between two companies, which have developed over the past several years. DNA Link and Amplicon Express have […]
Cartagenia Bench Addresses Inherent Challenges of Somatic Variant Assessment Agilent Technologies Inc. (NYSE: A) today released Cartagenia Bench Lab 5.0, a major new version of its lab software with new capabilities for somatic variant classification and reporting. Cartagenia Bench Lab is designed to help laboratories involved in clinical genetics and molecular pathology efficiently interpret and […]
Relationship provides Mayo Clinic early access to next-generation sequencing technologies; Illumina will obtain insights for ongoing product development SAN DIEGO & ROCHESTER, Minn.– Illumina, Inc. (NASDAQ: ILMN) today announced it has entered an agreement with Mayo Clinic to make advancements in next-generation sequencing technology with the intent to accelerate Mayo’s delivery of genetic and genomic […]
SAN DIEGO & ROCHESTER, Minn.– Illumina, Inc. (NASDAQ: ILMN) today announced it has entered an agreement with Mayo Clinic to make advancements in next-generation sequencing technology with the intent to accelerate Mayo’s delivery of genetic and genomic expertise. Together, the organizations plan to integrate existing services and software tools and employ new, innovative solutions to improve Mayo Clinic’s reporting workflows for […]
Hospitals and laboratories using the Sophia DDM® analytical platform in 35 countries will benefit from SOPHiA™ artificial intelligence combined with Archer® FusionPlex®, VariantPlex™, and Reveal ctDNA™ sample preparation kits LAUSANNE, Switzerland – Today, at the AMP 2016 Annual Meeting, Sophia Genetics, global leader in Data-Driven Medicine, and world-class Next-Generation Sequencing (NGS) assay developer ArcherDX, announced the […]
VANCOUVER, Wash. & CARLSBAD, Calif.–Sirona Dx, a leader in high complexity genomics and proteomics services, today announced it has adopted Thermo Fisher Scientific’s Oncomine Focus Assay to run on the Ion PGM System and will expand its drug development and next generation sequencing (NGS) services offered to pharmaceutical and clinical research clients. Sirona Dx recognizes […]
New middleware co-developed with Genohm ensures full chain of custody from Sample to Insight and integrates with most LIMS systems Hilden, Germany, and Charlotte, N.C. – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with lab informatics company Genohm to empower GeneReader NGS System users with seamless data management by integrating the […]
New improved chemistry for first Sample to Insight next-generation sequencing solution to be made available to first customers in December 2016 Charlotte, North Carolina, and Hilden, Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the validation of new and improved sequencing chemistry for its GeneReader NGS System, the world’s first complete […]
Empowering clinical research laboratories to achieve new levels of productivity SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) and GenomOncology today announced a distribution agreement to co-market the GO Clinical Workbench™ for molecular interpretation of somatic variants identified using Fluidigm systems. An elegant solution for clinical research laboratories seeking accuracy, flexibility, and scalability, this combined offering […]
LA JOLLA, Calif. – Synthetic Genomics, Inc., announced today that it has appointed industry veterans Tina Nova, Ph.D., and William McKee to its board of directors. “Tina and Bill have decades of experience growing dynamic commercial organizations in new markets within the pharmaceutical and healthcare diagnostics industries,” said Oliver Fetzer, Ph.D., chief executive officer of Synthetic […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
